🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a 28-week, open-label, multicenter, single-group Phase 2 explorato...
Status
Completed
Location
Travere Investigational Site
Start Date
2023-05-19
Trial ID
NCT05856760
Treatments Being Tested
ANCA-associated vasculitis is an autoimmune disease that causes damage to b...
Status
Active Not Recruiting
Location
Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent
Start Date
2022-12-08
Trial ID
NCT05630612
Treatments Being Tested
To evaluate the safety, efficacy and tolerability of sparsentan oral suspen...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2021-08-12
Trial ID
NCT05003986
Treatments Being Tested
This single-center, open-label, randomized, single and multiple-dose, 3-way...
Status
Completed
Location
Travere Investigational Site
Start Date
2020-06-18
Trial ID
NCT05562362
Treatments Being Tested
Single-center, open-label, two-stage pilot study examining the efficacy and...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-07-10
Trial ID
NCT07224776
Treatments Being Tested
To determine the long-term nephroprotective potential of treatment with spa...
Status
Completed
Location
Travere Investigational Site
Start Date
2018-04-17
Trial ID
NCT03493685
Treatments Being Tested
This study will investigate whether RE-021 (Sparsentan), a selective dual-a...
Status
Completed
Location
Balboa Nephrology Medical Group
Start Date
2014-03
Trial ID
NCT01613118
Treatments Being Tested
An observational study tracking the clinical course of patients with IgA ne...
Status
Not Yet Recruiting
Location
Stadtspital Zurich
Start Date
2026-06-01
Trial ID
NCT07555301
Treatments Being Tested
To determine the nephroprotective potential of treatment with sparsentan in...
Status
Recruiting
Location
Cambridge University Hospitals NHS Trust
Start Date
2020-12-10
Trial ID
NCT04663204
Treatments Being Tested
To evaluate the safety and efficacy of sparsentan tablets for the treatment...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-10-07
Trial ID
NCT07219121
Treatments Being Tested